BlossomHill Therapeutics Prices $150 Million IPO at $16 Per Share

3-line summary

• BlossomHill Therapeutics priced its IPO at $16 per share, raising $150 million, according to the report.

This summary is our own processing of the source article; see the source link below for full context.